advertisement
Tran MN 22
Showing records 1 to 22 | Display all abstracts from Tran MN109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Hodrea J
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Tran MN
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Hodrea J
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Tran MN
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Tran MN
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Medveczki T; Medveczki T
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Tran MN
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Besztercei B
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Besztercei B; Besztercei B
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Besztercei B
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Medveczki T; Medveczki T
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Torok G; Szabo AJ
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Szabo AJ
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Szabo AJ
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Szabo AJ
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Gasull X
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Őrfi L
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Kovacs I
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Kovacs I; Fekete A
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Fekete A; Fekete A
Life (Basel, Switzerland) 2023; 13:
109966 Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells
Fekete A
International journal of molecular sciences 2023; 24:
109969 Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells
Hodrea J; Hodrea J
Life (Basel, Switzerland) 2023; 13:
